JP2015049050A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015049050A5 JP2015049050A5 JP2013178620A JP2013178620A JP2015049050A5 JP 2015049050 A5 JP2015049050 A5 JP 2015049050A5 JP 2013178620 A JP2013178620 A JP 2013178620A JP 2013178620 A JP2013178620 A JP 2013178620A JP 2015049050 A5 JP2015049050 A5 JP 2015049050A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- test substance
- urine
- compounds represented
- dysuria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 18
- 238000012360 testing method Methods 0.000 claims 8
- 239000000126 substance Substances 0.000 claims 7
- 210000002700 urine Anatomy 0.000 claims 7
- 206010013990 dysuria Diseases 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 208000028938 Urination disease Diseases 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 206010020853 Hypertonic bladder Diseases 0.000 claims 3
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims 3
- 230000027939 micturition Effects 0.000 claims 3
- 208000020629 overactive bladder Diseases 0.000 claims 3
- 239000000090 biomarker Substances 0.000 claims 2
- 238000007689 inspection Methods 0.000 claims 2
- 238000005259 measurement Methods 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 230000007423 decrease Effects 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 238000010998 test method Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013178620A JP6222629B2 (ja) | 2013-08-29 | 2013-08-29 | 排尿障害のバイオマーカー |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013178620A JP6222629B2 (ja) | 2013-08-29 | 2013-08-29 | 排尿障害のバイオマーカー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015049050A JP2015049050A (ja) | 2015-03-16 |
| JP2015049050A5 true JP2015049050A5 (enExample) | 2016-07-28 |
| JP6222629B2 JP6222629B2 (ja) | 2017-11-01 |
Family
ID=52699210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013178620A Active JP6222629B2 (ja) | 2013-08-29 | 2013-08-29 | 排尿障害のバイオマーカー |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6222629B2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7031104B2 (ja) * | 2017-09-29 | 2022-03-08 | 国立大学法人山梨大学 | 難治性夜間頻尿・夜間多尿症バイオマーカー、これを用いた検査方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法 |
| JP7294709B2 (ja) * | 2017-09-29 | 2023-06-20 | 国立大学法人山梨大学 | 難治性夜間頻尿・夜間多尿症バイオマーカーの測定方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59162899A (ja) * | 1983-03-08 | 1984-09-13 | Kyoto Daiichi Kagaku:Kk | β‐ヒドロキシ酪酸の定量用組成物 |
| JP4779650B2 (ja) * | 2003-12-26 | 2011-09-28 | 小野薬品工業株式会社 | 高活性型リゾホスファチジン酸およびそれを用いたスクリーニング方法 |
| EP2597464B1 (en) * | 2007-08-16 | 2015-02-25 | The Regents of the University of Michigan | Metabolomic profiling of prostate cancer |
| ES2516866T3 (es) * | 2009-06-04 | 2014-10-31 | Metanomics Health Gmbh | Medios y métodos para el diagnóstico de carcinomas de próstata |
| JP2013515270A (ja) * | 2009-12-22 | 2013-05-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 前立腺癌の代謝学的プロファイリング |
| US20150065366A1 (en) * | 2011-11-11 | 2015-03-05 | Metabolon, Inc. | Biomarkers for Bladder Cancer and Methods Using the Same |
-
2013
- 2013-08-29 JP JP2013178620A patent/JP6222629B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kirişli et al. | Standardized evaluation framework for evaluating coronary artery stenosis detection, stenosis quantification and lumen segmentation algorithms in computed tomography angiography | |
| EP3264090A3 (en) | Method for detecting nucleosome adducts | |
| MX367046B (es) | Marcadores especificos de via para diagnosticar sindrome del intestino irritable. | |
| WO2016044338A3 (en) | Methods and systems for diagnosing sleep disorders | |
| JP2016500110A5 (enExample) | ||
| CA2863393A1 (en) | A multi-biomarker-based outcome risk stratification model for pediatric septic shock | |
| EP2759259A3 (en) | Apparatus and method for measuring stress based on a behavior of a user | |
| JP2018509934A5 (enExample) | ||
| BR112013006764A2 (pt) | método para avaliar um paciente, kit, meio legível por computador, método para avaliar um tratamento, método para avaliar o risco de um paciente, método para monitorar, método de diagnosticar, sistema de teste, método para classificar ou agrupar uma população de indivíduos, método para avaliar um desfecho substituto, método para tratar, uso de pelo menos um biomarcador, uso de um agente | |
| WO2015094995A3 (en) | Gene signature biomarkers of tumor response to pd-1 antagonists | |
| EP2579043A4 (en) | DETECTION METHOD | |
| WO2009001545A1 (ja) | 移植片対宿主疾患の検査および治療方法 | |
| JP2015520383A5 (enExample) | ||
| EA201290793A1 (ru) | Зонд для определения границ между веществами | |
| JP2017505897A5 (enExample) | ||
| EA201490946A1 (ru) | Способ количественной оценки лечения рака | |
| GB201014837D0 (en) | Biomarker signatures and uses thereof | |
| JP2017522951A5 (enExample) | ||
| JP2015049050A5 (enExample) | ||
| WO2012037199A3 (en) | Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles | |
| WO2014117680A3 (zh) | 外周血细胞TRPC6mRNA水平用于早期预测/诊断老年性痴呆 | |
| JP2010526995A5 (enExample) | ||
| WO2015006657A8 (en) | Method for the diagnosis and prognosis of cancer | |
| EP3665694A4 (en) | Systems and methods for improving disease diagnosis using measured analytes | |
| BR112012024175A2 (pt) | hbf e a1m como marcadores de estágio precoce para preeclampsia |